Therefore, it is expected that genes related to the IL-17A/IL-17F signaling pathway increases immune infiltration in breast cancer tissues, especially genes that encode downstream products of IL-17A/IL-17F signaling transduction. Here, IL17F is linked to breast carcinoma.